SCHEMBL2959263

SCHEMBL2959263

CCCCCCCCCCC1CCCCC(=O)O1

nearest known ligand 0.78

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.78
PPARG P37231 2/20 0.55
EPHX1 P07099 1/20 0.46
ALDH1A1 P00352 1/20 0.44
GRM2 Q14416 8/20 0.40
PRKCA P17252 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5685542 1.00 CYP1A2 (0.78) CYP1A2PPARGEPHX1ALDH1A1GRM2
SCHEMBL2148723 1.00 CYP1A2 (0.78) CYP1A2PPARGEPHX1ALDH1A1GRM2
SCHEMBL20357213 1.00 CYP1A2 (0.78) CYP1A2PPARGEPHX1ALDH1A1GRM2
SCHEMBL309599 1.00 CYP1A2 (0.78) CYP1A2PPARGEPHX1ALDH1A1GRM2
SCHEMBL1929554 1.00 CYP1A2 (0.78) CYP1A2PPARGEPHX1ALDH1A1GRM2
SCHEMBL19723850 1.00 CYP1A2 (0.78) CYP1A2PPARGEPHX1ALDH1A1GRM2
SCHEMBL20357214 1.00 CYP1A2 (0.78) CYP1A2PPARGEPHX1ALDH1A1GRM2
SCHEMBL15657477 1.00 CYP1A2 (0.78) CYP1A2PPARGEPHX1ALDH1A1GRM2
SCHEMBL15655829 0.98 CYP1A2 (0.76) CYP1A2PPARGEPHX1ALDH1A1GRM2
SCHEMBL15655925 0.98 CYP1A2 (0.76) CYP1A2PPARGEPHX1ALDH1A1GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118984846-A Compound, process for producing the same, composition, urethane resin, aqueous urethane resin dispersion, and coating agent 东曹株式会社 2024-11-19 CN disclosed
CN-118459735-A Organic compound, preparation method thereof and adhesive 上海天马微电子有限公司 2024-08-09 CN disclosed
WO-2024095283-A1 RECOMBINANT DNA, RECOMBINANT VECTOR FOR PRODUCING DELTA-ACYL LACTONES AND ITS IMPLEMENTATION THEREOF NATIONAL INSTITUTE OF IMMUNOLOGY (IN) 2024-05-10 WO disclosed
CN-108601958-B Pro-fragrance compositions 爱客多有限公司 2022-06-17 CN disclosed
CN-114040986-A Method of diagnosing disease 4D制药科克有限公司 2022-02-11 CN disclosed
EP-2735581-B1 COMPOSITION AND POLYMER ASAHI CHEMICAL IND (JP) 2021-07-14 EP disclosed
EP-3233974-A1 A PROCESS FOR THE PREPARATION OF A BLOCK COPOLYMER COMPRISING A FIRST POLYOLEFIN BLOCK AND A SECOND POLYMER BLOCK AS WELL AS THE PRODUCTS OBTAINED THEREFROM SABIC Global Technologies B.V. (NL) 2017-10-25 EP disclosed
EP-3233975-A1 A PROCESS FOR THE PREPARATION OF A GRAFT COPOLYMER COMPRISING A POLYOLEFIN MAIN CHAIN AND ONE OR A MULTIPLE POLYMER SIDE CHAINS AND THE PRODUCTS OBTAINED THEREFROM SABIC Global Technologies B.V. (NL) 2017-10-25 EP disclosed
US-9738757-B2 Composition and polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2017-08-22 US disclosed
EP-3089730-A1 DEODORANT COMPOSITIONS HAVING ANTIBACTERIAL AND ODOR BLOCKING PROPERTIES AND RELATED METHODS The Dial Corporation (US) 2016-11-09 EP disclosed
US-20140121293-A1 Composition and Polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-05-01 US disclosed
EP-2581077-A2 Olfactory adaption and cross-adapting agents to reduce the perception of body odors Symrise AG (DE) 2013-04-17 EP disclosed
US-20100254927-A1 OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS MONELL CHEMICAL SENSES CENTER (US) 2010-10-07 US disclosed
US-7763238-B2 Olfactory adaptation and cross-adapting agents to reduce the perception of body odors MONELL CHEMICAL SENSES CENTER (US) 2010-07-27 US disclosed
EP-1474095-A4 OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS MONELL CHEMICAL SENSES CENTRE (US) 2007-11-28 EP disclosed
US-20070020210-A1 Methods of reducing the perception of body odors with olfactory adaptation and cross-adapting agents MONELL CHEMICAL SENSES CENTER 2007-01-25 US disclosed
EP-1474095-A1 OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS MONELL CHEMICAL SENSES CENTER (US) 2004-11-10 EP disclosed
US-20030152538-A1 Olfactory adaptation and cross-adapting agents to reduce the perception of body odors SYMRISE INC. 2003-08-14 US disclosed
WO-2003061609-A1 OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS MONELL CHEMICAL SENSES CENTER (US) 2003-07-31 WO disclosed
US-20020095045-A1 Process for the preparation of macrocyclic esters SYMRISE GMBH & CO., KG (DE) 2002-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020095045-A1 Process for the preparation of macrocyclic esters CYP3A4, CYP4A11, CASP14 CYP1A2 108/4885PPARG 633/4885EPHX1 541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.